PMcardio

About PMcardio

PMcardio is an advanced AI-driven diagnostic platform designed to revolutionize cardiovascular care.

It quickly analyzes 12-lead ECG images—whether captured from paper, screens, or uploads—to detect over 40 conditions, including arrhythmias, heart blocks, chamber hypertrophies, and critical myocardial infarctions such as STEMI and its equivalents.

The platform offers instant, detailed reports with visual explainability heatmaps, enabling clinicians to interpret results confidently.

Validated in multiple independent studies, PMcardio enhances diagnostic sensitivity—up to twice that of standard care—and supports real-time decision-making.

Its AI models can identify life-threatening conditions early, improving patient outcomes and streamlining workflows.

Trusted by over 100,000 clinicians and used in more than 30 hospitals globally, PMcardio integrates seamlessly into existing clinical systems, offering scalable solutions for individual practitioners and large healthcare organizations.

Its compliance with international standards, including CE marking and GDPR, ensures safety, privacy, and regulatory adherence, making it a reliable tool for modern cardiology diagnostics..

Smart Features

• Rapid diagnosis of 38+ cardiovascular conditions in under 5 seconds
• AI-powered detection of STEMI and STEMI-equivalent patterns
• Explainability heatmaps for interpreting ECG features
• Supports detection of arrhythmias, conduction blocks, hypertrophies, and more
• Validated in 15+ independent clinical studies with proven high sensitivity
• Seamless integration with clinical workflows and electronic health records
• Trusted by over 100,000 clinicians and numerous hospitals worldwide
• Compliance with global standards including CE, GDPR, ISO certifications

Use Cases & Applications

• Emergency departments for rapid STEMI detection
• Primary care clinics for early cardiovascular screening
• Hospitals and cardiology centers for ongoing diagnostics
• Remote telemedicine consultations with instant ECG analysis
• Drug monitoring through detailed ECG interval measurements
• Research and clinical validation of ECG abnormalities

Who is it for?

• Cardiologists and emergency physicians
• Primary care providers and general practitioners
• Hospitals and healthcare institutions
• Medical researchers and clinical trial teams
• Telemedicine and remote diagnostic services

Business Opportunities in PMcardio

PMcardio offers a significant business opportunity for healthcare entrepreneurs and tech startups to integrate advanced AI diagnostics into their services.

By licensing or reselling the platform, partners can provide rapid cardiac assessments, support telemedicine initiatives, or develop specialized ECG analysis tools.

The scalable nature of PMcardio allows for expansion into remote clinics, primary care, or research projects, creating new revenue streams while improving patient outcomes.

Entrepreneurs can also develop training programs, customized integrations, and educational content around AI-driven cardiac diagnostics, leveraging the growing demand for fast, accurate, and accessible heart health assessments globally..